CASI PHARMACEUTICALS, INC. Costs and Expenses
CASI PHARMACEUTICALS, INC. (CASIF) reported Costs and Expenses of $55.08 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2026-05-15
| Period end | Costs and Expenses 12 month |
|---|---|
| 2025-12-31 | $55.08M 20-F · filed 2026-05-15 |
| 2024-12-31 | $50.77M 20-F · filed 2026-05-15 |
| 2023-12-31 | $45.13M 20-F · filed 2026-05-15 |
| 2022-12-31 | $61.31M 20-F · filed 2025-03-31 |
| 2021-12-31 | $59.13M 20-F · filed 2024-03-28 |
| 2020-12-31 | $58.41M 20-F · filed 2023-04-26 |